期刊文献+

鲍氏不动杆菌感染病区分布及耐药性分析 被引量:37

Ward Distribution and Drug Resistance Analysis of Acinetobacter baumannii
原文传递
导出
摘要 目的调查鲍氏不动杆菌感染病区分布及耐药性。方法常规细菌分离培养鉴定,琼脂纸片扩散法检测其对14种抗菌药物的敏感性。结果鲍氏不动杆菌最常出现于痰标本中,占60.7%,其次是分泌物标本,占15.7%;鲍氏不动杆菌感染全部为医院感染,以神经外科病房分布最多,占31.5%,其次是呼吸内科、重症监护病房(ICU)以及创伤骨科;对碳青酶烯类药物亚胺培南的耐药率最低,为13.5%,对其他13种抗菌药物的耐药率均〉50.0%;对庆大霉素和阿米卡星的耐药率为56.2%和60.7%,对环丙沙星、氯霉素、复方新诺明、哌拉西林的耐药率分别为53.9%、62.9%、62.9%、57.3%,对二、三代头孢类药物及单环8内酰胺类氨曲南的耐药率在51.7%~66.3%。结论鲍氏不动杆菌常引起医院感染,耐药现象严重,临床抗感染治疗应依据体外药物敏感试验结果合理选择抗菌药物,应加强医院环境和人员消毒,控制鲍氏不动杆菌在医院环境内的定植和播散。 OBJECTIVE To investigate the ward distribution and resistance of Acinetobacter baumannii. METHODS Bacteria culture and identification were adopted by conventional method. Susceptibility was tested by Kirby-Bauer method. RESULTS A. baumannii was the most isolated from sputum in all specimens, which accounted for 60.7%, being the highest percentage. Next was from secretion, accounted for 15.7%. A. baumannii was mainly distributed at wards, especially at neurosurgery ward. Next were at respiratary department, ICU and orthopedics wards. The resistance of A. baumannii were serious. Muti-drug resistance was common. The lowest drug resistance rate was to imipenem (13.5 %). For 13 antibacterial agents, the rates of drug resistances were higher than 50.0%. For gentamicin, amikacin, ciprofloxacin, chloramphenicol, sulfamethoxazole, and piperacillin, the rates of drug resistance were 56.2%, 60.7%,53.9%,62.9%,62.9% and 57.3%,respectively. For second and third generation cephlosporins, and aztreonam, the drug resistance rates were 51.7 % to 66.3 %. For cefoxitin and ampicillin, the drug resistance rates were higher to 89.9% and 91.0 %. CONCLUSIONS The resistance of A. baumannii causing nosocomial is serious. The reasonable use of antibacterial agents must based on the result of suseeptiblity test. The disinfection should be strengthened for hospital environment and medical staff in order to control existance and spread of A. baumannii in hospital.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第2期220-222,共3页 Chinese Journal of Nosocomiology
关键词 鲍氏不动杆菌 抗菌药物 耐药性 Acinetobacter baumannii Antibacterial agents Resistance
  • 相关文献

参考文献5

二级参考文献18

  • 1曹海燕.4a间鲍曼不动杆菌临床分析特点及耐药变迁[J].实用医技杂志,2006,13(2):208-209. 被引量:5
  • 2戴春梅,郑兰香,陈辉.129株鲍曼不动杆菌所致医院感染的耐药性分析[J].实用预防医学,2006,13(1):62-63. 被引量:25
  • 3冯红军,王邦松.不动杆菌耐药机制的研究现状[J].中国微生态学杂志,2006,18(2):149-150. 被引量:4
  • 4徐昌君,姜春娴,俞莲花,王冬国.鲍曼不动杆菌的分布特点及耐药性动态观察[J].中国微生态学杂志,2006,18(3):243-244. 被引量:5
  • 5Cisneros JM, Reyes MJ, Pachon J, et al.Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features[J].Clin Infect Dis, 1996, 22(6): 1026-1032.
  • 6Rodriguez BJ, Pascual A, Galvez J, et al.Acinetobacter baumannii bacteremia: clinical and prognostic features[J].Enferm Infect Microbiol Clin, 2003, 21(5): 242-247.
  • 7Ayan M, Durmaz R, Aktas E, et al.Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital[J].J Hosp Infect, 2003, 54(1): 39-45.
  • 8Donald HM, Scaife W, Amyes SG, et al.Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92[J].Antimicrob Agents Chemother, 2000, 44(1): 196-199.
  • 9Germ án B,Gonzalo C,M.Angeles D,et al.Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:high-level carbapenem resistance in A.baumannii is not due solely to the oresence of P-Lactamases[J].J Clin Microbiol,2000,38:3299 ~ 3305.
  • 10Alejandro B,Lourdes D,Anna R,et al.Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3[J].Antimicrob Agents Chemother,2004,48:1374 ~ 1378.

共引文献111

同被引文献196

引证文献37

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部